Sign Up to like & get recommendations! 2
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.51348
Abstract: This cohort study builds on previous research from the National Cancer Database to assess whether rates of bilateral mastectomy continue to increase. read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.7230
Abstract: Key Points Question The US Food and Drug Administration has promoted innovation in clinical trial design via the bayesian approach; does that make clinical trials more efficient? Findings In this bayesian analysis of a randomized… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2606
Abstract: To develop a nomogram for the local tumor progression (LTP) in patients with early‐stage hepatocellular carcinoma (HCC) after computed tomography‐guided percutaneous microwave ablation (CT‐PMWA) and to assess clinical‐pathologic risk factors for individual LTP estimation. Furthermore,… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4946
Abstract: Non‐small cell lung cancer (NSCLC) accounts for the majority of all lung cancer diagnoses, and approximately 35% of patients with NSCLC are diagnosed at an early stage (I–IIIA). This study aimed to describe epidermal growth… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.110_2629
Abstract: PET-based staging, PFS24 may not be a robust surrogate endpoint for OS. The improved outcomes in PET-staged patients with early progression may be associated with identification and exclusion of patients with transformed disease at time… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Journal of Neural Transmission"
DOI: 10.1007/s00702-018-1964-3
Abstract: Rasagiline is a monoamine oxidase B inhibitor with demonstrated efficacy and safety in patients with Parkinson’s disease (PD). We recently conducted the first randomized, double-blind, placebo-controlled trial of rasagiline in Japanese patients with early PD… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Clinical Rheumatology"
DOI: 10.1007/s10067-021-05695-7
Abstract: Despite erosions being as prevalent in feet as in hands in patients with rheumatoid arthritis (RA), their development in relation to synovitis and bone marrow edema (BME) have mainly been studied in hands. This study… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "International Urology and Nephrology"
DOI: 10.1007/s11255-017-1741-5
Abstract: Background/aimsZonulin is the only known regulator of intestinal permeability. It is also considered as a potential inflammatory marker in several conditions such as diabetes and inflammatory bowel syndrome. The aim of the study was to… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-018-3783-0
Abstract: ObjectiveDecreasing hospital length-of-stay (LOS) may be an effective strategy to reduce costs while also improving outcomes through earlier discharge to the non-hospital setting. The objective of the current study was to define the impact of… read more here.
Sign Up to like & get recommendations! 2
Published in 2021 at "Irish Journal of Medical Science"
DOI: 10.1007/s11845-021-02758-1
Abstract: We assessed the potential impact of a high dose of melatonin treatment in patients with early septic shock. Forty patients with early septic shock were randomly allocated to the melatonin or placebo groups. Besides standard-of-care… read more here.